rs189910531

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_001292063.2(OTOG):​c.8125G>A​(p.Asp2709Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00037 in 1,417,358 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00085 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00032 ( 0 hom. )

Consequence

OTOG
NM_001292063.2 missense

Scores

2
5
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7

Conservation

PhyloP100: 6.70

Publications

0 publications found
Variant links:
Genes affected
OTOG (HGNC:8516): (otogelin) The protein encoded by this gene is a component of the acellular membranes of the inner ear. Disruption of the orthologous mouse gene shows that it plays a role in auditory and vestibular functions. It is involved in fibrillar network organization, the anchoring of otoconial membranes and cupulae to the neuroepithelia, and likely in sound stimulation resistance. Mutations in this gene cause autosomal recessive nonsyndromic deafness, type 18B. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
OTOG Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 18B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.020392388).
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000316 (402/1272990) while in subpopulation MID AF = 0.00276 (14/5080). AF 95% confidence interval is 0.00167. There are 0 homozygotes in GnomAdExome4. There are 187 alleles in the male GnomAdExome4 subpopulation. Median coverage is 35. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGNM_001292063.2 linkc.8125G>A p.Asp2709Asn missense_variant Exon 51 of 56 ENST00000399397.6 NP_001278992.1 H9KVB3
OTOGNM_001277269.2 linkc.8161G>A p.Asp2721Asn missense_variant Exon 50 of 55 NP_001264198.1 Q6ZRI0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGENST00000399397.6 linkc.8125G>A p.Asp2709Asn missense_variant Exon 51 of 56 5 NM_001292063.2 ENSP00000382329.2 H9KVB3
OTOGENST00000399391.7 linkc.8161G>A p.Asp2721Asn missense_variant Exon 50 of 55 5 ENSP00000382323.2 Q6ZRI0-1

Frequencies

GnomAD3 genomes
AF:
0.000853
AC:
123
AN:
144264
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00180
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00160
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00654
Gnomad NFE
AF:
0.000379
Gnomad OTH
AF:
0.00100
GnomAD2 exomes
AF:
0.000273
AC:
40
AN:
146344
AF XY:
0.000278
show subpopulations
Gnomad AFR exome
AF:
0.00133
Gnomad AMR exome
AF:
0.000529
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000693
Gnomad NFE exome
AF:
0.000238
Gnomad OTH exome
AF:
0.000934
GnomAD4 exome
AF:
0.000316
AC:
402
AN:
1272990
Hom.:
0
Cov.:
35
AF XY:
0.000299
AC XY:
187
AN XY:
626408
show subpopulations
African (AFR)
AF:
0.00197
AC:
55
AN:
27912
American (AMR)
AF:
0.00119
AC:
38
AN:
31956
Ashkenazi Jewish (ASJ)
AF:
0.0000487
AC:
1
AN:
20522
East Asian (EAS)
AF:
0.00
AC:
0
AN:
24484
South Asian (SAS)
AF:
0.0000128
AC:
1
AN:
78058
European-Finnish (FIN)
AF:
0.0000286
AC:
1
AN:
34966
Middle Eastern (MID)
AF:
0.00276
AC:
14
AN:
5080
European-Non Finnish (NFE)
AF:
0.000265
AC:
265
AN:
1000128
Other (OTH)
AF:
0.000541
AC:
27
AN:
49884
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
25
49
74
98
123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000852
AC:
123
AN:
144368
Hom.:
0
Cov.:
32
AF XY:
0.000986
AC XY:
69
AN XY:
69950
show subpopulations
African (AFR)
AF:
0.00180
AC:
71
AN:
39488
American (AMR)
AF:
0.00160
AC:
23
AN:
14362
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3390
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4426
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4316
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9224
Middle Eastern (MID)
AF:
0.00709
AC:
2
AN:
282
European-Non Finnish (NFE)
AF:
0.000379
AC:
25
AN:
65984
Other (OTH)
AF:
0.000992
AC:
2
AN:
2016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000655
Hom.:
0
Bravo
AF:
0.000865
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ExAC
AF:
0.0000946
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 05, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 23, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 2721 of the OTOG protein (p.Asp2721Asn). This variant is present in population databases (rs189910531, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with OTOG-related conditions. ClinVar contains an entry for this variant (Variation ID: 504840). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Autosomal recessive nonsyndromic hearing loss 18B Uncertain:2
Mar 24, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 26, 2019
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

not specified Uncertain:1
Jan 10, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Asp2721Asn variant in OTOG has not been previously reported in individuals with hearing loss, but has been identified in 1/868 of African chromosomes and 1/272 Latino chromosomes by the Exome Aggregation Consortium (ExAC, http://exac. broadinstitute.org; dbSNP rs189910531). Although this variant has been seen in t he general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analysis do not provide s trong support for or against an impact to the protein. In summary, the clinical significance of the p.Asp2721Asn variant is uncertain. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.30
T;.
Eigen
Benign
0.030
Eigen_PC
Benign
0.018
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.84
T;T
M_CAP
Benign
0.077
D
MetaRNN
Benign
0.020
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.4
M;.
PhyloP100
6.7
PrimateAI
Uncertain
0.57
T
PROVEAN
Uncertain
-3.7
D;.
REVEL
Benign
0.20
Sift
Benign
0.072
T;.
Sift4G
Pathogenic
0.0
D;D
Vest4
0.58
MVP
0.15
ClinPred
0.060
T
GERP RS
3.7
Varity_R
0.26
gMVP
0.86
Mutation Taster
=69/31
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs189910531; hg19: chr11-17662573; API